Loading patent…
AssigneeInnoplexus AG
InventorsOm Sharma, Vijay Singh, Manoj Kumar, Ishita Mallick, Amit Choudhari, Pulkit Anupam Srivastava, Deepak Sharma, Vivekanand Patil, Priyam Singh, Adity Shandilya, Dinesh Solanke
Estimating the term…
A phosphoinositide 3-kinase inhibitor for use in the treatment of pancreatic cancer and a method for treatment of pancreatic cancer including administration of an phosphoinositide 3-kinase inhibitor an Src inhibitor to a human subject in need thereof. There is also provided a pharmaceutical composition comprising a phosphoinositide 3-kinase inhibitor and an Src inhibitor.
A phosphoinositide 3-kinase inhibitor for use in the treatment of pancreatic cancer, wherein the phosphoinositide 3-kinase inhibitor is for use in combination therapy with an Src inhibitor.
A method for treatment of pancreatic cancer comprising administration of an phosphoinositide 3-kinase inhibitor and an Src inhibitor to a human subject in need thereof.
A pharmaceutical composition comprising a phosphoinositide 3-kinase inhibitor and an Src inhibitor.
An Src inhibitor for use in the treatment of pancreatic cancer, wherein the Src inhibitor is for use in combination therapy with a phosphoinositide 3-kinase inhibitor.
Dependencies are inferred from the claim text.